FDA 483 - Pharmaceutics International, Inc. - September 29, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA inspection of Pharmaceutics International, Inc. in Cockeysville, MD, a sterile drug manufacturer, revealed significant and repeat deficiencies across quality control, aseptic processing, and facility maintenance. These issues include failures in thoroughly investigating discrepancies, ensuring data integrity, preventing microbiological contamination, and maintaining proper environmental controls. The findings indicate systemic problems that could impact the quality and safety of manufactured drug products, leading to product recalls.
ID · 98c0fefd-6d0c-4a86-ac7d-593085f5d47e